Published in

Instituto Nacional de Salud Pública, Salud Pública de México, (51), p. s296-s304

DOI: 10.1590/s0036-36342009000800020

Links

Tools

Export citation

Search in Google Scholar

Costo-efectividad de políticas para el tamizaje de cáncer de mama en México

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown
Data provided by SHERPA/RoMEO

Abstract

Objective. Generate cost-effectiveness information to allow policy makers optimize breast cancer (BC) policy in Mexico. Material and methods. We constructed a Markov model that incorporates four interrelated processes of the disease: the natural history; detection using mammography; treatment; and other competing-causes mortality, according to which 13 different strategies were modeled. Results. Strategies (starting age, % of coverage, frequency in years)= (48, 25, 2), (40, 50, 2) and (40, 50, 1) constituted the optimal method for expanding the BC program, yielding 75.3, 116.4 and 171.1 thousand pesos per life-year saved, respectively.Conclusions: The strategies included in the optimal method for expanding the program produce a cost per life-year saved of less than two times the GNP per capita and hence are cost-effective according to WHO Commission on Macroeconomics and Health criteria.